Site search
Correspondence address
310 Mira Street, Stavropol, Russia, 355017
Tel
+7 865 2352511, +7 865 2353229.
E-mail
medvestnik@stgmu.ru
The journal is included into The list of leading scientific periodicals.
The journal is included into VINITI database and is registered in Electronic scientific library.
The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.
As shown recent literary data, Parkinson’s disease is a chronopathological phenomenon with disorganization of daily rhythms numerous physiological processes. These shifts based on the disturbance of hypothalamic suprachiasmatic nuclei and its interrelations with pineal gland. Attenuation of rhythm stabilization role and neuroprotective influence main pineal hormone melatonin on nigrostriatal dopaminergic neurons may be important pathogenic reason for this disease.
References:
1. Arushanian E. B. Jurn. Vysh. Nervn. Dejat. – J. High Nerv. Activ. 1996;46:15-22.
2. Arushanian E. B., Ovanesov K. B. Farmakol. i toksicol. – Pharmacol. and Toxicol. 1988;51:38-42.
3. Arushanian E. B., Popov A. V. Uspechi. fisiol. nauk – Adv. Physiol. Sci. 2011;42:39-58.
4. Litvinenko I. V. Bolezn Parkinsona. M. 2010. 216 р. 5. Acuna-Castroviejo D., Escames G., Venega C. Cell. Mol. Life Sc. 2014;76:2997-3025.
6. Breen D. P., Vuono R., Nawarathna U. JAMA Neurol. 2014;71:589-595.
7. Cai J., Liu S., Sothern R. B. Eur. Neurol. 2010;17:550- 554.
8. DeBruyne J. P., Weaver D. R., Reppert S. M. Nat. Neurosci. 2007;10:543-545.
9. Devos D. J. Neural. Transm. 2003;110:997-1011.
10. Fifel K., Vezoli J., Dzahini K. PloS One. 2014;9:e86240.
11. Kudo T., Loh D. H., Truong D. Exp. Neurol. 2011;232:66- 75.
12. Laudon M., Frydman-Marom A. Int. J. Mol. Sci. 2014;15:15024-15950.
13. Li J. D., Hu W. P., Zhou Q. J. Progr. Brain Res. 2012;199:119-127.
14. Lin L., Du Y., Yuan S. Brain Res. 2014;1547:3-48.
15. Ma J., Shaw V. E., Mitrofanis J. Parkinsonian Relat. Disord. 2009;15:307-314.
16. Masson-Pevet M. J. Soc. Biol. 2007;201:77-83.
17. Mattam U., Jagota A. Biogerontology. 2014;15:257- 268.
18. Musiek E. S., Lim M. N., Jang G. J. Clin. Invest. 2013;123:5389-5400.
19. Naskar A., Prabhakar V., Singh R. J. Pineal Res. 2015;58:262-274.
20 Nawa F., Kuriyama N., Nakagawa M. Auton. Nervosci. 2011;165:195-200.
21. Raggi A., Bella R., Pennisi G. Rev. Neurosci. 2013;24:279-291.
22. Scott F. F., Belle M. D., Delagrange P. J. Neuroendicrinol. 2010;22:1148-1156.
23. Sharma R., McMillan C. R., Tenn C. C. Brain Res. 2006;1068:230-236.
24. Srinivasan V., Cardinali D. P., Srinivasan U. S. Ther. Adv. Neurol. Disord. 2011;4:297-317.
25. Videnovic A., Golombek D. Exp. Neurol. 2013;243:45- 56.
26. Videnovic A., Lazap A. S., Baker R. A. Nat. Rev. Neurol. 2014;10:683-693.
Keywords: Parkinson’s disease, dopaminergic mechanisms, melatonin